Mink Therapeutics

Price & Volume

Stats

52W Range	$4.56-$76
Market Cap	$52M
Shares Short	34,041

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$3.01

News

Yahoo Finance • 20 days ago

MiNK Therapeutics GAAP EPS of -$0.65 beats by $0.20

Yahoo Finance • 20 days ago

MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

Yahoo Finance • 27 days ago

MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

Yahoo Finance • 29 days ago

MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development

About

CEO	Dr. Jennifer S. Buell Ph.D.
Address	149 Fifth Avenue, New York, NY, United States, 10010
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	23